A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40+
SponsorGenetesis Inc.

About this trial

A multicenter observational data development registry collecting diagnostic measures via standard of care (SOC) cardiac PET in order gain a better understanding of how CardioFlux MCG may be used in the detection of coronary ischemia.

Eligibility criteria

Qualifiers

Willing to provide informed consent

Male or female, aged 40 and up (inclusive) at the time of enrollment

Clinical suspicion of myocardial ischemia that clinician desired cardiac PET

Completed cardiac PET within 2 weeks prior to study enrollment

Disqualifiers

Patients unable to fit into CardioFlux device.

Patients unable to lie supine for 5 minutes.

Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable

Ongoing atrial fibrillation or atrial flutter

Trial design

Treatments tested in this trial

  • CardioFlux Magnetocardiography

Treatment groups

300 Participants
are divided into 2 treatment groups

Sponsors and collaborators